Sentinel lymph node biopsy and breast cancer

British Journal of Surgery

Volumn 89, Issue 1, 2002, Pages 21-34

  Noguchi, M ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; EOSIN; HEMATOXYLIN; RADIOISOTOPE; TRACER;

AXILLARY LYMPH NODE; BREAST CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISSECTION; FEASIBILITY STUDY; FROZEN SECTION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; LYMPHOSCINTIGRAPHY; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE BIOPSY; STAINING; STANDARDIZATION;

AXILLA; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; INTRAOPERATIVE CARE; LYMPHATIC METASTASIS; RADIOISOTOPES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0036135852     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1323.2001.01962.x     Document Type: Review

References (115)

1. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
2. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection
3. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
4. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
5. The sentinel node in breast cancer. A multicenter validation study
6. Lymphatic mapping and sentinel node biopsy in the patients with breast cancer
7. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
8. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma
9. A preliminary study of cost
10. Improved axillary staging of breast cancer with sentinel lymphadenectomy
11. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques
12. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients
13. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer
14. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: Univariate and multivariate analysis of 966 procedures
15. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society
16. Sentinel lymph node mapping in breast cancer
17. Meta-analysis of sentinel lymph node biopsy in breast cancer
18. Credentialing for breast lymphatic mapping: How many cases are enough?
19. Mapping a pathway for axillary staging: A personal perspective on the current status of sentinel lymph node dissection for breast cancer
20. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
21. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
22. Intradermal blue dye to identify sentinel lymph node in breast cancer
23. Technical details of intraoperative lymphatic mapping for early stage melanoma
24. Sentinel lymph node involvement - A predictor for axillary node status with breast cancer - Has the time come?
25. Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits
26. Sentinel lymph node detection and imaging
27. Gamma probe guided sentinel node biopsy in breast cancer
28. Optimized sentinel node scintigraphy in breast cancer
29. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
30. Development of sentinel node targeting technique in breast cancer patients
31. Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered
32. Sentinel lymphadenectomy in breast cancer: Identification of sentinel lymph node and detection of metastases
33. Staging efficacy of breast cancer with sentinel lymphadenectomy
34. Efficacy and significance of sentinel lymph node identification with technetium-99m-labeled tin colloids for breast cancer
35. Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization
36. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
37. Gamma probe-guided sentinel node biopsy - Optimal timing for injection
38. Mammary lymphoscintigraphy in breast cancer
39. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
40. Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients: Efficacy of filtered technetium 99m sulfur colloid with overnight migration time
41. Lymphoscintigraphy and sentinel node localization in breast cancer patients: A comparison between 1-day and 2-day protocols
42. The gamma-probe-guided resection of radiolabeled primary lymph nodes
43. State-of-the-art approaches to sentinel node biopsy for breast cancer: Study design, patient selection, technique, and quality control at Memorial Sloan- Kettering Cancer Center
44. Sentinel-node biopsy in breast cancer
45. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients
46. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer
47. Extra-axillary sentinel lymph nodes in breast cancer
48. Lymphatic mapping and sentinel lymph node biopsy in breast cancer
49. Comparison of 2cc vs 6cc of radiopharmaceutical diluent in injections for breast lymphatic mapping
50. Unfiltered sulfur colloid and sentinel node biopsy for breast cancer: Technical and kinetic considerations
51. How to do sentinel node biopsy in breast cancer
52. Lymphatic mapping with intralesional tracer administration in breast carcinoma patients
53. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
54. Subareolar versus peritumoral injection for location of the sentinel lymph node
55. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye
56. Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients
57. The role of sentinel lymph node biopsy in breast cancer
58. In search of the true sentinel node by different injection techniques in breast cancer patients
59. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy
60. Breast lymphatic mapping using subareolar injection of blue dye and radiocolloid: Illustrated technique
61. Sentinel lymph node biopsy in breast cancer patients: Subdermal versus peritumoral radiocolloid injection
62. Intradermal isotope injection: A highly accurate method of lymphatic mapping in breast carcinoma
63. Clinical and histological factors associated with sentinel node identification in breast cancer
64. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer
65. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes
66. Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology
67. Inefficacy of internal mammary nodes dissection in breast cancer surgery
68. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial
69. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes
70. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer
71. Lymph node micrometastases from breast carcinoma: Reviewing the dilemma
72. Staging of breast cancer: A new rationale for internal mammary node biopsy
73. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
74. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
75. Internal mammary chain sentinel lymph node identification in breast cancer
76. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
77. Histological findings of internal mammary lymph node chain in patients undergoing extended radical mastectomy
78. National practice patterns of sentinel lymph node dissection for breast carcinoma
79. Pathological investigation of sentinel lymph nodes
80. Sentinel node biopsy in the staging of breast cancer
81. Serial sectioning of sentinel nodes in patients with breast cancer: A pilot study
82. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
83. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma
84. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node
85. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma
86. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study
87. Dye-guided sentinel lymphadenectomy in clinically node-negative and node-positive breast cancer patients
88. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer
89. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients
90. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer
91. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer
92. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer
93. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery
94. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients
95. Intraoperative pathologic examination of the sentinel lymph node
96. Four large studies aim to resolve sentinel node debate
97. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
98. RT-PCR detection of breast cancer cells in sentinel lymph nodes
99. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
100. Detection of metastatic breast cancer by beta-HCG polymerase chain reaction
101. Diagnosis of axillary lymph node metastases in patients with breast cancer
102. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes
103. Prognostic significance of breast cancer axillary lymph node metastases assessed by two special techniques: Reevaluation with longer follow-up
104. Breast cancer: Two micrometastatic variants in the axilla that differ in prognosis
105. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
106. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
107. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients?
108. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
109. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors
110. 2 breast cancer
111. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
112. Sentinel node biopsy in breast cancer: An overview
113. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer
114. Lymphatic mapping and sentinel lymph node biopsy
115. The role of axillary lymph node dissection in breast cancer management